株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

末梢動脈疾患 (PAD) /末梢血管疾患 (PVD):世界の治験動向

Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Global Clinical Trials Review, H1, 2018

発行 GlobalData 商品コード 289942
出版日 ページ情報 英文 323 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.43円で換算しております。
Back to Top
末梢動脈疾患 (PAD) /末梢血管疾患 (PVD):世界の治験動向 Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Global Clinical Trials Review, H1, 2018
出版日: 2018年04月30日 ページ情報: 英文 323 Pages
概要

当レポートでは、世界の末梢動脈疾患 (PAD) /末梢血管疾患 (PVD) 治療薬の治験 について調査分析し、地域・進捗状況・フェーズ (相) ・募集状況別の実施件数や、代表的なスポンサー、開発中の治療薬の情報、治験プロファイルなどを提供しています。

当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要5カ国における治験件数
    • 中南米の主要5カ国における治験件数

G7諸国での治験件数:心血管疾患治療薬の治験における末梢動脈疾患 (PAD) /末梢血管疾患 (PVD) の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:心血管疾患治療薬の治験における末梢動脈疾患 (PAD) /末梢血管疾患 (PVD) の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

末梢動脈疾患 (PAD) /末梢血管疾患 (PVD) 治療薬の治験に携わっている主要企業

有望な薬剤

最新の治験ニュース

治験プロファイルの概要

付録

目次
Product Code: GDHC4957CTIDB

GlobalData's clinical trial report, "Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Global Clinical Trials Review, H1, 2018" provides an overview of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) clinical trials scenario. This report provides top line data relating to the clinical trials on Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Five Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) to Cardiovascular Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) to Cardiovascular Clinical Trials 19
  • Clinical Trials by Phase in E7 Countries 20
  • Clinical Trials in E7 Countries by Trial Status 21
  • Clinical Trials by Phase 22
  • In Progress Trials by Phase 23
  • Clinical Trials by Trial Status 24
  • Clinical Trials by End Point Status 25
  • Subjects Recruited Over a Period of Time 26
  • Clinical Trials by Sponsor Type 27
  • Prominent Sponsors 28
  • Top Companies Participating in Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials 29
  • Prominent Drugs 30
  • Latest Clinical Trials News on Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) 31
  • Apr 02, 2018: Symic Bio Announces 12-Month Results from the SHIELD Trial of SB-030 in Peripheral Vascular Disease 31
  • Mar 05, 2018: Symic Bio Announces Results of Locally-Administered Therapeutic SB-030 in Preclinical Model of Vascular Intervention 31
  • Clinical Trial Profile Snapshots 32

Appendix 321

  • Abbreviations 321
  • Definitions 321
  • Research Methodology 322
  • Secondary Research 322
  • About GlobalData 323
  • Contact Us 323
  • Source 323

List of Tables

List of Tables

  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials by Region, 2018* 8
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15
  • Proportion of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) to Cardiovascular Clinical Trials, G7 Countries (%), 2018* 16
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
  • Proportion of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) to Cardiovascular Clinical Trials, E7 Countries (%), 2018* 19
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials by Phase, 2018* 22
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 23
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 27
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 29
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 30

List of Figures

List of Figures

  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials by Region (%), 2018* 8
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15
  • Proportion of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) to Cardiovascular Clinical Trials, G7 Countries (%), 2018* 16
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
  • Proportion of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) to Cardiovascular Clinical Trials, E7 Countries (%), 2018* 19
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 22
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 23
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 27
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 29
  • Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 30
  • GlobalData Methodology 322
Back to Top